The Comprehensive A I Driven Genomic Landscape for ALS Implications for Drug Discovery and Develo

Presented By: Mark Kiel, MD, PhD

Speaker Biography: Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development.

Webinar: The Comprehensive A.I.-Driven Genomic Landscape for ALS - Implications for Drug Discovery and Development

Webinar Abstract: Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting approximately 1 in 50,000 people worldwide. About 10% of these cases are found to have a hereditary component, but lack of routine genetic testing for those with family history suggests that the number could be much higher.

Earn P.A.C.E. Credits:
2. Watch the webinar on YouTube or on the LabRoots Website (Link to Microsite)

LabRoots on Social:
SnapChat: labroots_inc